Benchmark indices ended flat, amid a choppy trading session, as investors turned cautious on concerns that the weak monsoon would further accelerate inflation while the continuing crisis in Iraq also weighed on sentiment.
However, IT stocks firmed up on the back of upbeat performance from Accenture Plc.
The 30-share BSE index closed 37.25 points higher at 25,099.92 levels and 50-share NSE index ended up 15.60 points at 7,508.80 levels.
Asian Markets:
Asian shares ended weak, weighed down by a weak performance on Wall Street and doubts about the strength of the U.S. economy, which pushed bonds higher. China's Shanghai Composite and Singapore's Straits Times lost 0.1% and 0.2%, each.
Furthermore, Japan's Nikkei share average fell to its lowest in 10 day on Friday as investors took profits, while overall sentiment suffered from brewing concerns over a weak US economy and the yen's strength. On the other hand, Hong Kong's Hang Seng gained 0.1%.
Crude:
Oil prices edged lower in Asia today following lackluster US economic data that fuelled bearish sentiment about demand in the world’s top crude consumer.
At 3.40 Pm, the Brent Crude is currently quoting at $113.19 and the rupee is trading at Rs. 60.14 against the US dollar on the back of weak local equities.
Rain Check:
Monsoons remained inadequate (31% below average) till 25th of June. The shortage of rainfall is bound to hurt farm output and spur inflation, thus reducing the scope for monetary easing by the central bank.
Buzzing stocks:
Investors sought refuge in the defensive Pharma space with Ranbaxy Laboratories ended 5% to Rs 497 on reports that it has received the US Food and Drug Administration (US FDA)'s approval to sell a generic version of Novartis's hypertension medicine, Diovan.
Dr Reddy's Labs closed 1.7% higher after the pharma major launched duloxetine delayed-release capsules USP 20 mg, 30 mg and 60 mg in the US market. In addition, Sun Pharma ended up 4%.
IT shares jumped on the back of improving demand environment after Accenture Plc reported better-than-expected revenue for the third quarter ended May 31, 2014